** Genetic testing company GeneDx WGS.O shares slump 41.5% to $68.43 and set for biggest one-day fall on record
** Co posts Q1 rev of $87.1 mln, down 8.6% from last quarter's $95.3 mln
** Reports net loss of $6.5 mln, or 23 cents per share, in Q1
** WGS, however, beats analysts' estimates for Q1 results and forecasts full-year revenue above estimates- LSEG data
** Three out of 6 analysts rate stock as "buy" or higher, 3 "hold"; Median PT is $109.50
** At last close, WGS was trading at over two-year high of $117.75
** Including session's moves, WGS down ~11% YTD
(Reporting by Twesha Dikshit)
((Twesha.Dikshit@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。